Hepatitis B is a serious liver infection that affects millions of people worldwide. Caused by the hepatitis B virus, this condition has a significant impact on public health and individual well-being. It can lead to both acute and chronic liver disease, posing substantial risks to those infected.
This article aims to provide a comprehensive overview of hepatitis B. It will explore the nature of the virus, discuss common symptoms and risk factors, and highlight effective treatment options. Additionally, it will shed light on prevention strategies and management techniques to help individuals better understand and cope with this widespread health concern.
The Hepatitis B Virus
![](https://hameha.com/wp-content/uploads/2024/07/3-93.png)
![](https://hameha.com/wp-content/uploads/2024/07/4-90.png)
![](https://hameha.com/wp-content/uploads/2024/07/1-94.png)
![](https://hameha.com/wp-content/uploads/2024/07/2-93.png)
The hepatitis B virus (HBV) is a small DNA virus that belongs to the Hepadnaviridae family. It has a complex structure and an unusual replication cycle that involves reverse transcription. HBV is a prototype virus of this family, and related viruses are found in other mammals such as woodchucks, ground squirrels, and ducks.
Structure and types
HBV particles consist of an outer lipid envelope containing the surface antigen (HBsAg) and an inner nucleocapsid composed of the core antigen (HBcAg) complexed with the viral DNA genome and polymerase. The genome is a partially double-stranded circular DNA of about 3.2 kilobase pairs. HBV is classified into eight genotypes (A to H) based on sequence comparison, each with a distinct geographic distribution.
The virus has three morphologic forms:
- Infectious virions (Dane particles) – 42 nm double-shelled structures
- Spherical particles – 20-22 nm in diameter, composed of HBsAg without viral nucleic acids
- Tubular forms – also composed of HBsAg, non-infectious
The genome encodes four overlapping open reading frames (ORFs): S, C, P, and X. The S ORF encodes the viral surface envelope proteins, while the C ORF encodes the nucleocapsid HBcAg or hepatitis B e antigen (HBeAg). The P ORF encodes the viral polymerase, and the X ORF encodes a protein (HBxAg) with multiple functions.
RELATED: Complete Guide to Gastritis: Symptoms, Causes, and Treatments
Lifecycle in the body
HBV replication begins with the virus attaching to and entering liver cells (hepatocytes). The viral genome is then transported to the nucleus, where it is converted into a covalently closed circular DNA (cccDNA) form. This cccDNA serves as a template for transcription of viral RNAs.
The pregenomic RNA (pgRNA) is reverse transcribed by the viral polymerase to form new viral DNA genomes. These are then packaged into nucleocapsids along with the polymerase and core protein. The nucleocapsids can either be enveloped and secreted as mature virions or cycled back to the nucleus to maintain a pool of cccDNA. This unique replication cycle allows HBV to persist in infected cells.
Impact on the liver
HBV primarily infects hepatocytes and can cause acute or chronic hepatitis B infection. In acute infection, the virus replicates extensively in the liver, leading to immune-mediated inflammation and damage. Most adults are able to clear the infection, but 5-10% develop chronic hepatitis B.
Chronic HBV infection is characterized by persistent viral replication and hepatocyte injury. Over time, this can progress to cirrhosis (scarring of the liver) and significantly increase the risk of hepatocellular carcinoma (liver cancer). The pathogenesis of liver damage is thought to be largely mediated by the host immune response rather than direct cytopathic effects of the virus.
The complex structure and unique replication strategy of HBV make it a challenging virus to control. Understanding its lifecycle and impact on the liver is crucial for developing effective strategies for prevention, diagnosis, and treatment of hepatitis B.
Recognizing Hepatitis B
Not all people with acute hepatitis B virus (HBV) infection have symptoms. Symptoms can range from asymptomatic or mild disease to, rarely, fulminant hepatitis. The presence of signs and symptoms varies by age. Infants and children under 5 years old with acute HBV infection are typically asymptomatic. People younger than 30 years old are less likely to be symptomatic compared with persons 30 years and older.
Most people with chronic HBV infection are asymptomatic and have no evidence of liver disease or injury. However, some people develop chronic hepatitis (elevation of aspartate aminotransferase [AST]/alanine aminotransferase [ALT]), cirrhosis, or hepatocellular carcinoma (i.e., primary liver cancer).
Early warning signs
When present, signs and symptoms for acute hepatitis B appear an average of 90 days after exposure, but range from 60–150 days. Common symptoms of acute hepatitis B are:
- Abdominal pain, nausea, and/or vomiting
- Dark urine or clay-colored stools
- Fatigue
- Fever
- Jaundice
- Joint pain
- Loss of appetite
For many people, symptoms of acute hepatitis B infections last anywhere from 6 weeks up to 6 months. In some cases, the infection can progress to chronic hepatitis, primary liver cancer, or cirrhosis.
Complications of chronic infection
About 1 in 20 people who get hepatitis B as adults become “carriers,” which means they have a chronic (long-lasting) hepatitis B infection. Carriers are more likely to pass hepatitis B to other people. Most carriers are contagious — meaning they can spread hepatitis B — for the rest of their lives.
Hepatitis B infections that last a long time may lead to serious liver diseases like cirrhosis and liver cancer. About 1 in 5 people with chronic hepatitis B die from it. There are medicines that can help treat chronic hepatitis B infections.
When to see a doctor
If you have any symptoms of hepatitis B, it’s important to check with a doctor or nurse for testing. Hepatitis B usually will go away by itself, but it may become chronic and seriously damage your liver.
Most babies who get hepatitis B develop chronic infection, unless they get treated right away. But treatments almost always work if your baby gets them quickly. That’s why it’s important for pregnant people to get tested for hepatitis B.
High-Risk Groups
Certain groups are at a higher risk of contracting hepatitis B virus (HBV) due to their occupational or lifestyle factors. These high-risk groups include healthcare workers, intravenous drug users, and individuals with sexual transmission risks.
Healthcare workers
Healthcare personnel (HCP) who come into contact with human blood, blood products, or potentially infectious bodily fluids are at an increased risk for exposure to the hepatitis B virus. The Centers for Disease Control and Prevention (CDC) recommends that all healthcare workers, emergency personnel, and other individuals who are exposed to blood or bodily fluids on the job should be vaccinated against hepatitis B.
Access to treatment can be a significant barrier for people who inject drugs (PWID), who may face stigma and discrimination in healthcare settings. In a recent study, 88% of individuals from PWID have experienced some type of stigma from the healthcare system, such as being poorly treated by nurses, security guards, and other medical providers. Due to these biases, people often refuse to seek health care services to avoid mistreatment.
RELATED: Everything About Folliculitis: From Causes to Treatment
Intravenous drug users
People who inject drugs (PWID) are at high risk for hepatitis B virus infection due to various factors, including sharing injection equipment and lack of awareness about hepatitis B transmission. Using unclean needles to inject drugs can result in the exchange of blood, increasing a person’s risk of being exposed to the virus. Hepatitis B prevalence among PWID is much higher than in the general population, with chronic HBV infection identified in 3.5% to 20.0% of PWID in various settings.
One effective prevention strategy to combat the spread of hepatitis B among PWID is to use clean injection equipment, like needles, works, and syringes. New services, such as syringe exchange programs, have been introduced in cities like Philadelphia to decrease the rate of sharing needles and reduce the risk of hepatitis B and other infectious diseases being spread in the community.
Sexual transmission risks
Hepatitis B is easily transmitted through sexual activity, and sexual contact is the most common way hepatitis B is spread in the United States. Hepatitis B is 50-100 times more infectious than HIV. If an individual is sexually active, getting vaccinated against hepatitis B and talking to a health professional about the risk for STDs and HIV is crucial.
Certain sexual behaviors and factors can increase the risk of hepatitis B transmission:
- Having multiple sexual partners
- Engaging in unprotected sex (not using condoms)
- Having a sexually transmitted disease (STD)
- Men who have sexual encounters with other men
The best way to prevent hepatitis B is to get vaccinated. The hepatitis B vaccine is safe and effective, and it is recommended for sexually active adults, especially those with multiple sex partners, anyone with an STD, men who have sexual encounters with other men, and anyone having sex with an infected partner.
Managing Hepatitis B
People living with chronic hepatitis B infection should expect to live a long and healthy life. There are decisions people can make to protect their livers such as seeing a liver specialist or health care provider regularly, avoiding alcohol and tobacco, and eating healthy foods. There are also approved drugs for both adults and children that control the hepatitis B virus, which helps reduce the risk of developing more serious liver disease, but there is still no complete cure.
Treatment options
Current treatments for hepatitis B fall into two general categories:
- Immune modulator Drugs – These are interferon-type drugs that boost the immune system to help get rid of the hepatitis B virus. They are given as a shot over 6 months to 1 year.
- Antiviral Drugs – These are drugs that stop or slow down the hepatitis B virus from reproducing, which reduces the inflammation and damage of your liver. These are taken as a pill once a day for at least 1 year and usually longer.
It is important to know that not everyone with chronic hepatitis B infection needs to be treated. This can be difficult to accept when first diagnosed because taking a drug to get rid of the virus seems like the first step to getting better. Current treatments, however, are generally found to be most effective in those who show signs of active liver disease.
Whether you start treatment or not, it is very important to be regularly seen by a liver specialist or a health care provider who is knowledgeable about hepatitis B. The standard recommendation is every 6 months, but some people may be checked more often or even just once a year. During these check-up visits, your provider will monitor your health through a physical exam, blood tests and imaging studies to make sure that you are staying healthy and to detect any liver problems as early as possible.
Monitoring liver health
Hepatitis B can be a complicated liver infection to understand, so additional blood tests may be ordered so your health provider has a better understanding of what kind of care and follow-up is needed. Some of the most common liver related blood tests are:
- ALT (alanine aminotransferase) – This test is useful in deciding whether a patient would benefit from treatment or for evaluating how well a person is responding to therapy.
- AST (aspartate aminotransferase) – This enzyme is often ordered to help monitor potential liver damage from the hepatitis B virus.
- AFP (Alpha-FetoProtein) – This test is used to screen for primary liver cancer in patients with chronic hepatitis B. If the AFP level is high, the health care provider will order more blood tests and imaging studies.
Your doctor may also perform a physical examination, ultrasound, or fibroscan to assess the degree of liver fibrosis and scarring and monitor the progression of liver disease.
RELATED: Flea Bites in Humans: Symptoms, Treatment, and Prevention
Coping strategies
In addition to medical treatment and monitoring, there are many other things patients can do to protect their liver and improve their health:
- Schedule regular visits with your liver specialist or health care provider to stay on top of your health and the health of your liver.
- Get the Hepatitis A vaccine to protect yourself from another virus that attacks the liver.
- Avoid drinking alcohol and smoking since both will hurt your liver, which is already being injured by the hepatitis B virus.
- Talk to your provider before starting any herbal remedies or vitamin supplements because some could interfere with your prescribed hepatitis B drugs or even damage your liver.
- Eat a healthy diet of fruit, whole grains, fish and lean meats, and lots of vegetables. “Cruciferous vegetables” in particular — cabbage, broccoli, cauliflower — have been shown to help protect the liver against environmental chemicals.
- Reduce your stress levels by eating healthy foods, exercising regularly, and getting plenty of rest.
Keep in mind everything you eat, drink, breathe, or absorb through the skin is eventually filtered by the liver. So protect your liver and your health by making smart lifestyle choices and working closely with your healthcare provider to manage your hepatitis B infection.
Conclusion
Hepatitis B remains a significant global health concern, with far-reaching effects on individuals and communities. This article has shed light on the virus’s structure, symptoms, high-risk groups, and management strategies. Understanding the complexities of hepatitis B has a crucial role in promoting effective prevention, early detection, and treatment. The ongoing efforts to educate the public and healthcare providers about this disease are vital to reduce its spread and impact.
While there’s no complete cure for chronic hepatitis B yet, advancements in treatment options and monitoring techniques offer hope for those affected. By staying informed, getting vaccinated, and making healthy lifestyle choices, individuals can protect themselves and others from this serious liver infection. To tackle hepatitis B effectively, it’s essential to continue research, improve access to healthcare, and foster a supportive environment for those living with the condition.